- $918.66m
- $758.46m
- $180.04m
- 67
- 15
- 42
- 36
Annual income statement for Couchbase, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 82.5 | 103 | 124 | 155 | 180 |
Cost of Revenue | |||||
Gross Profit | 74.7 | 91.7 | 109 | 135 | 158 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 106 | 136 | 180 | 224 | 265 |
Operating Profit | -23.7 | -33.1 | -56.3 | -69.3 | -84.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -28.5 | -38.9 | -57.2 | -67.5 | -78.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29.3 | -40 | -58.2 | -68.5 | -80.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.3 | -40 | -58.2 | -68.5 | -80.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29.3 | -44.1 | -61.1 | -68.5 | -80.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.81 | -1.06 | -1.39 | -1.51 | -1.63 |
Dividends per Share |